Executives Find This Toy Maker’s Shares Attractive After Stock Price Plunges, Plus Other Insider Trading

Executives at Medical Device Maker Offloads Shares After Releasing Fourth-Quarter Results

Two members of Boston Scientific Corporation (NYSE:BSX)’s executive team offloaded shares this week. To start with, Eric Francis Yves Thepaut, Senior Vice President and President of Europe, discarded 23,775 shares on Monday at prices that ranged between $24.93 and $24.95 per share, a sale that cut his ownership to 98,457 shares. Keith D. Dawkins, Executive Vice President and Global Chief Medical Officer, liquidated 80,783 shares on Tuesday at a weighted average price of $25.21 per share. Dr. Dawkins currently owns 75,864 shares following the sale.

The shares of the medical-technology marker are trading a few cents off their 52-week high of $25.38, after having gained 16% year-to-date. The company’s shares gained after unveiling fourth-quarter results that beat expectations. According to an analyst at BMO Capital Markets, Boston Scientific Corporation (NYSE:BSX) “ended 2016 on a very good note, and enters 2017 with a promising product pipeline and lots of momentum to avoid a sophomore slump.” The medical device maker reported sales of $2.19 billion for the fourth quarter, which increased by 11% year-over-year on a reported and operational basis. Meanwhile, Boston Scientific’s management expects 2017 sales to range from $8.675 billion-to-$8.875 billion, as compared to $8.386 billion recorded for 2016. Peter Algert and Kevin Coldiron’s Algert Coldiron Investors owned around 70,000 shares of Boston Scientific Corporation (NYSE:BSX) at the end of 2016.

Two Insiders at Milacron Holdings Unload Shares

Several insiders at Milacron Holdings Corp (NYSE:MCRN) also trimmed their equity stakes at the beginning of the week. Chief Executive Officer Thomas J. Goeke sold 179,233 shares on Monday at $15.60 apiece, cutting his ownership stake to 60,625 shares. Board member Waters S. Davis IV offloaded 19,079 shares on the same day for $15.60 each. Mr. Davis currently owns a total of 29,776 shares following the sale.

The shares of the industrial technology company serving the plastic processing industry have gained 46% in the past 12 months. Earlier this year, Milacron Holdings Corp (NYSE:MCRN) reported preliminary results for the fourth quarter and full year that ended December. The company anticipates to report sales between $287.0 million and $289.0 million for the fourth quarter of 2016, down from $306.3 million for the same period of the previous year. Unfavorable foreign currency movements hit the company’s sales figure by $4.5 million. John A. Levin’s Levin Capital Strategies L.P. had 3.29 million shares of Milacron Holdings Corp (NYSE:MCRN) in its portfolio at the end of September.

Disclosure: None